|Genomma Lab Internacional S A B de C V -- Mexico Stock|| |
MXN 21 0.05 0.24%
Vice-President of Fin. and Admin.
Mr. Oscar Villalobos Torres served as Executive Vice President of Finance and Administration of Genomma Lab Internacional S.A.B. de C.V. till December 15 2015. Previously he acted as Chief Financial Officer of the Company from October 24 2008. He has also served at Grupo IMSA and International de Ceramica . He holds a Masters degree in Business Administration from Universidad Autonoma de Chihuahua a Bachelors degree in Finance and Management from the University of Texas a postgraduate degree in Corporationrationrate Law and International Business from Georgetown University a degree in Advanced Management from Instituto Panamericano de Alta Direccion de Empresa and a degree in Finance from Instituto Tecnologico y de Estudios Superiores Monterrey.
52 55 5081 0000 http://www.genommalab.com
The company has return on total asset (ROA)
of 12.93 %
which means that it generated profit of $12.93 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 15.99 %
meaning that it generated $15.99 on every $100 dollars invested by stockholders.
The company has accumulated 5.8 B in total debt with debt to equity ratio (D/E) of 91.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Genomma Lab Internacional S A B de C V has Current Ratio of 1.49 which is within standard range for the sector.
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, develops, markets, and sells overthecounter pharmaceutical products, generic drugs, and personal care solutions in Mexico and internationally. Genomma Lab Internacional S A B de C V (LABB) is traded on Mexico Stock Exchange in Mexico. It is located in Mexico City, DF and employs 799 people.